Atypical hemolytic uremic syndrome (aHUS) is a devastating form of renal thrombotic
microangiopathy. In the last five years, we have finally witnessed a dramatic improvement in …

In the last decade, significant progress has been made in the understanding and the
treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS). aHUS has emerged …

Background Atypical haemolytic uremic syndrome (aHUS) is a rare but severe form of
thrombotic microangiopathy as a consequence of complement dysregulation. aHUS has a …

Background Atypical hemolytic uremic syndrome (aHUS) is a form of thrombotic
microangiopathy characterized by uncontrolled activation of the alternative complement …

Atypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy (TMA) that is
driven by uncontrolled activation of the alternative complement pathway, classically in the …

Atypical hemolytic uremic syndrome (aHUS) is a life-threatening thrombotic
microangiopathy, and as many as 70% of patients with aHUS have mutations in the genes …

Atypical hemolytic uremic syndrome (aHUS) is a rare thrombotic microangiopathy (TMA)
characterized by the triad of hemolytic anemia, thrombocytopenia, and acute renal failure …

Background: The management of atypical hemolytic uremic syndrome (aHUS) has evolved
into better control of thrombotic microangiopathy (TMA) and recovery of renal functions since …

Background Atypical hemolytic uremic syndrome (aHUS) is a rare genetic life-threatening
disease of chronic uncontrolled complement activation leading to thrombotic …

Atypical hemolytic uremic syndrome (aHUS) is caused by alternative complement pathway
dysregulation, leading to systemic thrombotic microangiopathy (TMA) and severe end-organ …